Patents by Inventor Hebing XIE

Hebing XIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180117036
    Abstract: The present invention relates to an oral pharmaceutical composition for increasing hypoxia tolerance, characterized in that the pharmaceutical composition comprises active ingredient L-carnitine or derivative thereof or pharmaceutically acceptable salt thereof, active ingredient trimetazidine or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable auxiliary material, and 100:1 is the weight ratio of L-carnitine or derivative thereof or pharmaceutically acceptable salt thereof and trimetazidine or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 28, 2017
    Publication date: May 3, 2018
    Inventors: Hebing XIE, Qingyi LI, Shuhua GU, Weihong LV
  • Patent number: 9421181
    Abstract: The present invention discloses an antihypoxic pharmaceutical composition and application thereof. The pharmaceutical composition contains vinpocetine and L-carnitine or a derivative thereof and a pharmaceutically acceptable salt thereof, and also can contain trimetazidine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: August 23, 2016
    Inventors: Hebing Xie, Qingyi Li, Shuhua Gu, Weihong Lv
  • Publication number: 20160106741
    Abstract: The present invention relates to an oral pharmaceutical composition for increasing hypoxia tolerance, characterized in that the pharmaceutical composition comprises active ingredient L-carnitine or derivative thereof or pharmaceutically acceptable salt thereof, active ingredient trimetazidine or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable auxiliary material, and 100:1 is the weight ratio of L-carnitine or derivative thereof or pharmaceutically acceptable salt thereof and trimetazidine or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 22, 2014
    Publication date: April 21, 2016
    Applicant: CHANGZHOU HI-TECH DISTRICT MULTIPLE DIMENSION INDUSTRY TECHNOLOGY INSTITUTE CO.
    Inventors: Hebing XIE, Qingyi LI, Shuhua GU, Weihong LV
  • Publication number: 20160081966
    Abstract: The present invention discloses an antihypoxic pharmaceutical composition and application thereof. The pharmaceutical composition contains vinpocetine and L-carnitine or a derivative thereof and a pharmaceutically acceptable salt thereof, and also can contain trimetazidine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 21, 2014
    Publication date: March 24, 2016
    Inventors: Hebing XIE, Qingyi LI, Shuhua GU, Weihong LV